Table of Contents Global Sterile Intravenous (IV) Solution Market Research Report 2021, Forecast to 2026 1 Market Study Overview 1.1 Study Objectives 1.2 Sterile Intravenous (IV) Solution Introduce 1.3 Combined with the Analysis of Macroeconomic Indicators 1.4 Brief Description of Research methods 1.5 Market Breakdown and Data Triangulation 2 Global Trend Summary 2.1 Sterile Intravenous (IV) Solution Segment by Type 2.1.1 Crystalloids 2.1.2 Colloids 2.1.3 Others 2.2 Market Analysis by Application 2.2.1 Medications 2.2.2 NutritionNutrition 2.2.3 Blood-based Products 2.2.4 Others 2.3 Global Sterile Intravenous (IV) Solution Market Comparison by Regions (2016-2026) 2.3.1 Global Sterile Intravenous (IV) Solution Market Size (2016-2026) 2.3.2 North America Sterile Intravenous (IV) Solution Status and Prospect (2016-2026) 2.3.3 Europe Sterile Intravenous (IV) Solution Status and Prospect (2016-2026) 2.3.4 China Sterile Intravenous (IV) Solution Status and Prospect (2016-2026) 2.3.5 Japan Sterile Intravenous (IV) Solution Status and Prospect (2016-2026) 2.3.6 Southeast Asia Sterile Intravenous (IV) Solution Status and Prospect (2016-2026) 2.4 Basic Product Information 2.4.1 Basic Product Information & Technology Development History 2.4.2 Product Manufacturing Process 2.4.3 Interview with Major Market Participants 2.4.4 High-end Market Analysis and Forecast 2.5 Coronavirus Disease 2019 (Covid-19): Sterile Intravenous (IV) Solution Industry Impact 2.5.1 Sterile Intravenous (IV) Solution Business Impact Assessment - Covid-19 2.5.2 Market Trends and Sterile Intravenous (IV) Solution Potential Opportunities in the COVID-19 Landscape 2.5.3 Measures / Proposal against Covid-19 3 Competition by Manufacturer 3.1 Global Sterile Intravenous (IV) Solution Sales and Market Share by Manufacturer (2016-2021) 3.2 Global Sterile Intravenous (IV) Solution Revenue and Market Share by Manufacturer (2016-2021) 3.3 Global Sterile Intravenous (IV) Solution Industry Concentration Ratio (CR5 and HHI) 3.4 Top 5 Sterile Intravenous (IV) Solution Manufacturer Market Share 3.5 Top 10 Sterile Intravenous (IV) Solution Manufacturer Market Share 3.6 Date of Key Manufacturers Enter into Sterile Intravenous (IV) Solution Market 3.7 Key Manufacturers Sterile Intravenous (IV) Solution Key Manufacturers 3.8 Mergers & Acquisitions Planning 4 Analysis of Sterile Intravenous (IV) Solution Industry Key Manufacturers 4.1 B. Braun Medical Inc. 4.1.1 Compan Detail 4.1.2 B. Braun Medical Inc. Sterile Intravenous (IV) Solution Product Introduction, Application and Specification 4.1.3 B. Braun Medical Inc. 161 Sales, Price, Cost, Gross Margin, and Revenue (2016-2021) 4.1.4 Main Business Overview 4.1.5 B. Braun Medical Inc. News 4.2 Technoflex 4.2.1 Compan Detail 4.2.2 Technoflex Sterile Intravenous (IV) Solution Product Introduction, Application and Specification 4.2.3 Technoflex Sterile Intravenous (IV) Solution Sales, Price, Cost, Gross Margin, and Revenue (2016-2021) 4.2.4 Main Business Overview 4.2.5 B. Braun Medical Inc. News 4.3 Baxter International 4.3.1 Compan Detail 4.3.2 Baxter International Sterile Intravenous (IV) Solution Product Introduction, Application and Specification 4.3.3 Baxter International Sterile Intravenous (IV) Solution Sales, Price, Cost, Gross Margin, and Revenue (2016-2021) 4.3.4 Main Business Overview 4.3.5 Baxter International News 4.4 ICU Medical, Inc 4.4.1 Compan Detail 4.4.2 ICU Medical, Inc Sterile Intravenous (IV) Solution Product Introduction, Application and Specification 4.4.3 ICU Medical, Inc Sterile Intravenous (IV) Solution Sales, Price, Cost, Gross Margin, and Revenue (2016-2021) 4.4.4 Main Business Overview 4.4.5 ICU Medical, Inc News 4.5 Mckesson 4.5.1 Compan Detail 4.5.2 ICU Medical, Inc Sterile Intravenous (IV) Solution Product Introduction, Application and Specification 4.5.3 Mckesson Sterile Intravenous (IV) Solution Sales, Price, Cost, Gross Margin, and Revenue (2016-2021) 4.5.4 Main Business Overview 4.5.5 Mckesson News 4.6 Amsino 4.6.1 Compan Detail 4.6.2 Amsino Sterile Intravenous (IV) Solution Product Introduction, Application and Specification 4.6.3 Amsino Sterile Intravenous (IV) Solution Sales, Price, Cost, Gross Margin, and Revenue (2016-2021) 4.6.4 Main Business Overview 4.6.5 Amsino News 4.7 Wallcur 4.7.1 Compan Detail 4.7.2 Wallcur Sterile Intravenous (IV) Solution Product Introduction, Application and Specification 4.7.3 Wallcur Sterile Intravenous (IV) Solution Sales, Price, Cost, Gross Margin, and Revenue (2016-2021) 4.7.4 Main Business Overview 4.7.4 Main Business Overview 4.8 Hebei Guangren Pharmaceutical Technology 4.8.1 Compan Detail 4.8.2 Hebei Guangren Pharmaceutical Technology Sterile Intravenous (IV) Solution Product Introduction, Application and Specification 4.8.3 Hebei Guangren Pharmaceutical Technology Sterile Intravenous (IV) Solution Sales, Price, Cost, Gross Margin, and Revenue (2016-2021) 4.8.4 Main Business Overview 4.8.5 Hebei Guangren Pharmaceutical Technology News 4.9 Jiangsu Hengfengqiang Biotechnology 4.9.1 Compan Detail 4.9.2 Jiangsu Hengfengqiang Biotechnology Sterile Intravenous (IV) Solution Product Introduction, Application and Specification 4.9.3 Jiangsu Hengfengqiang Biotechnology Sterile Intravenous (IV) Solution Sales, Price, Cost, Gross Margin, and Revenue (2016-2021) 4.9.4 Main Business Overview 4.9.5 Jiangsu Hengfengqiang Biotechnology News 4.10 Hospira 4.10.1 Compan Detail 4.10.2 Hospira Sterile Intravenous (IV) Solution Product Introduction, Application and Specification 4.10.3 Hospira Sterile Intravenous (IV) Solution Sales, Price, Cost, Gross Margin, and Revenue (2016-2021) 4.10.4 Main Business Overview 4.10.5 Hospira News 4.11 Jiangsu Hengfengqiang Biotechnology 4.11.1 Compan Detail 4.11.2 Jiangsu Hengfengqiang Biotechnology Sterile Intravenous (IV) Solution Product Introduction, Application and Specification 4.11.3 Jiangsu Hengfengqiang Biotechnology Sterile Intravenous (IV) Solution Sales, Price, Cost, Gross Margin, and Revenue (2016-2021) 4.11.4 Main Business Overview 4.11.5 Jiangsu Hengfengqiang Biotechnology News 4.12 Hospira 4.12.1 Compan Detail 4.12.2 Hospira Sterile Intravenous (IV) Solution Product Introduction, Application and Specification 4.12.3 Hospira Sterile Intravenous (IV) Solution Sales, Price, Cost, Gross Margin, and Revenue (2016-2021) 4.12.4 Main Business Overview 4.12.5 Hospira News 4.13 Xi'an Libang Alliance Enterprise Management 4.13.1 Company Details 4.13.2 Xi'an Libang Alliance Enterprise Management Sterile Intravenous (IV) Solution Product Introduction, Application and Specification 4.13.3 Xi'an Libang Alliance Enterprise Management Sterile Intravenous (IV) Solution Sales, Price, Cost, Gross Margin, and Revenue (2016-2021) 4.13.4 Main Business Overview 4.13.5 Xi'an Libang Alliance Enterprise Management News 4.14 Livzon Group 4.14.1 Compan Detail 4.14.2 Livzon Group Sterile Intravenous (IV) Solution Product Introduction, Application and Specification 4.14.3 Livzon Group Sterile Intravenous (IV) Solution Sales, Price, Cost, Gross Margin, and Revenue (2016-2021) 4.14.4 Main Business Overview 4.14.5 Livzon Group News 5 Global Sterile Intravenous (IV) Solution Market Segment by Big Type 5.1 Global Sterile Intravenous (IV) Solution Revenue, Sales and Market Share by Big Type (2016-2021) 5.1.1 Global Sterile Intravenous (IV) Solution Sales and Market Share by Big Type (2016-2021) 5.1.2 Global Sterile Intravenous (IV) Solution Revenue and Market Share by Big Type (2016-2021) 5.2 Crystalloids Sales Growth Rate and Price 5.2.1 Global Crystalloids Sales Growth Rate (2016-2021) 5.2.2 Global Crystalloids Price (2016-2021) 5.3 Colloids Sales Growth Rate and Price 5.3.1 Global Colloids Sales Growth Rate (2016-2021) 5.3.2 Global Colloids Price (2016-2021) 5.4 Others Sales Growth Rate and Price 5.4.1 Global Others Sales Growth Rate (2016-2021) 5.4.2 Global Others Price (2016-2021) 6 Global Sterile Intravenous (IV) Solution Market Segment by Big Application 6.1 Global Sterile Intravenous (IV) Solution Sales Market Share by Big Application (2016-2021) 6.2 Medications Sales Growth Rate (2016-2021) 6.3 NutritionNutrition Sales Growth Rate (2016-2021) 6.4 Blood-based Products Sales Growth Rate (2016-2021) 6.5 Others Sales Growth Rate (2016-2021) 7 Global Sterile Intravenous (IV) Solution Forecast 7.1 Global Sterile Intravenous (IV) Solution Revenue, Sales and Growth Rate (2021-2026) 7.2 Sterile Intravenous (IV) Solution Market Forecast by Regions (2021-2026) 7.2.1 North America Sterile Intravenous (IV) Solution Market Forecast (2021-2026) 7.2.2 Europe Sterile Intravenous (IV) Solution Market Forecast (2021-2026) 7.2.3 China Sterile Intravenous (IV) Solution Market Forecast (2021-2026) 7.2.4 Japan Sterile Intravenous (IV) Solution Market Forecast (2021-2026) 7.2.5 Southeast Asia Sterile Intravenous (IV) Solution Market Forecast (2021-2026) 7.2.6 Other Regions Sterile Intravenous (IV) Solution Market Forecast (2021-2026) 7.3 Sterile Intravenous (IV) Solution Market Forecast by Type (2021-2026) 7.3.1 Global Sterile Intravenous (IV) Solution Sales Forecast by Type (2021-2026) 7.3.2 Global Sterile Intravenous (IV) Solution Market Share Forecast by Type (2021-2026) 7.4 Sterile Intravenous (IV) Solution Market Forecast by Application (2021-2026) 7.4.1 Global Sterile Intravenous (IV) Solution Sales Forecast by Application (2021-2026) 7.4.2 Global Sterile Intravenous (IV) Solution Market Share Forecast by Application (2021-2026) 8 Market Analysis 8.1.1 Market Overview 8.1.2 Market Opportunities 8.1.3 Market Risk 8.1.4 Market Driving Force 8.1.5 Porter's Five Forces Analysis 8.1.6 SWOT Analysis 9 Sterile Intravenous (IV) Solution Related Market Analysis 9.1 Upstream Analysis 9.1.1 Macro Analysis of Upstream Markets 9.1.2 Key Players in Upstream Markets 9.1.3 Upstream Market Trend Analysis 9.1.4 Sterile Intravenous (IV) Solution Manufacturing Cost Analysis 9.2 Downstream Market Analysis 9.2.1 Macro Analysis of Down Markets 9.2.2 Key Players in Down Markets 9.2.3 Downstream Market Trend Analysis 9.2.4 Sales Channel, Distributors, Traders and Dealers 10 Research Findings and Conclusion

List of Tables and Figures Figure Product Picture Sterile Intravenous (IV) Solution Figure Market Concentration Ratio and Market Maturity Analysis of Sterile Intravenous (IV) Solution Figure Bottom-up and Top-down Approaches for This Report Figure Part of Our External Database Figure Part of Our External Database Figure Key Executives Interviewed Table Global Sterile Intravenous (IV) Solution Market Size by Big Type Figure Global Market Share of Sterile Intravenous (IV) Solution by Big Type in 2020 Figure Crystalloids Picture (2016-2021) Figure Colloids Picture (2016-2021) Global Sterile Intravenous (IV) Solution Market Size by Big Application Table Global Sterile Intravenous (IV) Solution Market Size by Application Figure Global Sterile Intravenous (IV) Solution Market Share by Big Application in 2020 Figure Medications Picture Figure NutritionNutrition Picture Figure Blood-based Products Picture Figure Others Picture Table Global Sterile Intravenous (IV) Solution Comparison by Regions (M USD) （2016-2026） Figure Global Sterile Intravenous (IV) Solution Market Size (Million US$) (2016-2026) Figure North America Sterile Intravenous (IV) Solution Revenue (Million US$) Growth Rate (2016-2026) Figure Europe Sterile Intravenous (IV) Solution Revenue (Million US$) Growth Rate (2016-2026) Figure China Sterile Intravenous (IV) Solution Revenue (Million US$) Growth Rate (2016-2026) Figure Japan Sterile Intravenous (IV) Solution Revenue (Million US$) Growth Rate (2016-2026) Figure Southeast Asia Sterile Intravenous (IV) Solution Revenue (Million US$) Growth Rate (2016-2026) Table Business Impact Assessment - Covid-19 Table Market Trends and Sterile Intravenous (IV) Solution Potential Opportunities in the COVID-19 Landscape Table Measures / Proposal against Covid-19 Table Global Sterile Intravenous (IV) Solution Sales by Manufacturer (2016-2021) Figure Global Sterile Intravenous (IV) Solution Sales Market Share by Manufacturer in 2020 Table Global Sterile Intravenous (IV) Solution Revenue by Manufacturer (2016-2021) Figure Global Sterile Intravenous (IV) Solution Revenue Market Share by Manufacturer in 2020 Table Global Sterile Intravenous (IV) Solution Manufacturers Market Concentration Ratio (CR5 and HHI) Figure Top 5 Sterile Intravenous (IV) Solution Manufacturer (Revenue) Market Share in 2020 Figure Top 10 Sterile Intravenous (IV) Solution Manufacturer (Revenue) Market Share in 2020 Table Date of Key Manufacturers Enter into Sterile Intravenous (IV) Solution Market Table Key Manufacturers Sterile Intravenous (IV) Solution Product Type Table Mergers & Acquisitions Planning Table B. Braun Medical Inc. Company Profile Table Sterile Intravenous (IV) Solution Product Introduction, Application and Specification of B. Braun Medical Inc. Table Sterile Intravenous (IV) Solution Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Company One 2016-2021 Table Company One Main Business Table Company One Recent Development Table Technoflex Company Profile Table Sterile Intravenous (IV) Solution Product Introduction, Application and Specification of Technoflex Table Sterile Intravenous (IV) Solution Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Company Two 2016-2021 Table Technoflex Recent Development Table Baxter International Company Profile Table Sterile Intravenous (IV) Solution Product Introduction, Application and Specification of Baxter International Table Sterile Intravenous (IV) Solution Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Company Two 2016-2021 Table Baxter International Main Business Table Baxter International Recent Development Table ICU Medical, Inc Company Profile Table Sterile Intravenous (IV) Solution Product Introduction, Application and Specification of ICU Medical, Inc Table Sterile Intravenous (IV) Solution Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Company Two 2016-2021 Table ICU Medical, Inc Main Business Table ICU Medical, Inc Recent Development Table ICU Medical, Inc Main Business Table ICU Medical, Inc Recent Development Table Mckesson Company Profile Table Sterile Intravenous (IV) Solution Product Introduction, Application and Specification of Mckesson Table Sterile Intravenous (IV) Solution Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Company Two 2016-2021 Table Mckesson Main Business Table Mckesson Recent Development Table Amsino Company Profile Table Sterile Intravenous (IV) Solution Product Introduction, Application and Specification of Amsino Table Sterile Intravenous (IV) Solution Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Company Two 2016-2021 Table Amsino Main Business Table Amsino Recent Development Table Wallcur Company Profile Table Sterile Intravenous (IV) Solution Product Introduction, Application and Specification of Wallcur Table Sterile Intravenous (IV) Solution Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Company Two 2016-2021 Table Wallcur Main Business Table Wallcur Recent Development Table Hebei Guangren Pharmaceutical Technology Company Profile Table Sterile Intravenous (IV) Solution Product Introduction, Application and Specification of Hebei Guangren Pharmaceutical Technology Table Sterile Intravenous (IV) Solution Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Company Two 2016-2021 Table Hebei Guangren Pharmaceutical Technology Main Business Table Hebei Guangren Pharmaceutical Technology Recent Development Table Jiangsu Hengfengqiang Biotechnology Company Profile Table Sterile Intravenous (IV) Solution Product Introduction, Application and Specification of Jiangsu Hengfengqiang Biotechnology Table Sterile Intravenous (IV) Solution Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Company Two 2016-2021 Table Jiangsu Hengfengqiang Biotechnology Main Business Table Jiangsu Hengfengqiang Biotechnology Recent Development Table Hospira Company Profile Table Sterile Intravenous (IV) Solution Product Introduction, Application and Specification of Hospira Table Sterile Intravenous (IV) Solution Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Company Two 2016-2021 Table Hospira Main Business Table Hospira Recent Development Table Jiangsu Hengfengqiang Biotechnology Company Profile Table Sterile Intravenous (IV) Solution Product Introduction, Application and Specification of Jiangsu Hengfengqiang Biotechnology Table Sterile Intravenous (IV) Solution Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Company Two 2016-2021 Table Jiangsu Hengfengqiang Biotechnology Main Business Table Jiangsu Hengfengqiang Biotechnology Recent Development Table Hospira Company Profile Table Sterile Intravenous (IV) Solution Product Introduction, Application and Specification of Hospira Table Sterile Intravenous (IV) Solution Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Company Two 2016-2021 Table Hospira Main Business Table Hospira Recent Development Table Xi'an Libang Alliance Enterprise Management Company Profile Table Sterile Intravenous (IV) Solution Product Introduction, Application and Specification of Xi'an Libang Alliance Enterprise Management Table Sterile Intravenous (IV) Solution Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Company Two 2016-2021 Table Xi'an Libang Alliance Enterprise Management Main Business Table Xi'an Libang Alliance Enterprise Management Recent Development Table Livzon Group Company Profile Table Sterile Intravenous (IV) Solution Product Introduction, Application and Specification of Livzon Group Table Sterile Intravenous (IV) Solution Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Company Two 2016-2021 Table Livzon Group Main Business Table Livzon Group Recent Development Figure Global Sterile Intravenous (IV) Solution Sales and Growth Rate (2016-2021) Figure Global Sterile Intravenous (IV) Solution Revenue and Growth Rate (2016-2021) Table Global Sterile Intravenous (IV) Solution Sales by Regions (2016-2021) Figure Global Sterile Intravenous (IV) Solution Sales Market Share by Regions in 2020 Table Global Sterile Intravenous (IV) Solution Revenue by Regions (2016-2021) Figure Global Sterile Intravenous (IV) Solution Revenue Market Share by Regions in 2020 Figure North America Sterile Intravenous (IV) Solution Sales and Growth Rate (2016-2021) Figure Europe Sterile Intravenous (IV) Solution Sales and Growth Rate (2016-2021) Figure China Sterile Intravenous (IV) Solution Sales and Growth Rate (2016-2021) Figure Japan Sterile Intravenous (IV) Solution Sales and Growth Rate (2016-2021) Figure Southeast Asia Sterile Intravenous (IV) Solution Sales and Growth Rate (2016-2021) Figure Other Regions Sterile Intravenous (IV) Solution Sales and Growth Rate (2016-2021) Table Global Sterile Intravenous (IV) Solution Sales by Big Type (2016-2021) Table Global Sterile Intravenous (IV) Solution Sales Market Share by Big Type (2016-2021) Figure Global Sterile Intravenous (IV) Solution Sales Market Share by Big Type in 2019 Table Global Sterile Intravenous (IV) Solution Revenue by Big Type (2016-2021) Table Global Sterile Intravenous (IV) Solution Revenue Market Share by Big Type (2016-2021) Table Global Sterile Intravenous (IV) Solution Revenue Market Share by Big Type in 2019 Figure Global Crystalloids Sales Growth Rate (2016-2021) Figure Global Crystalloids Price (2016-2021) Figure Global Colloids Sales Growth Rate (2016-2021) Figure Global Colloids Price (2016-2021) Figure Global Others Sales Growth Rate (2016-2021) Table Global Sterile Intravenous (IV) Solution Sales by Big Application (2016-2021) Table Global Sterile Intravenous (IV) Solution Sales Market Share by Big Application (2016-2021) Figure Global Sterile Intravenous (IV) Solution Sales Market Share by Big Application in 2019 Figure Global Medications Sales Growth Rate (2016-2021) Figure Global NutritionNutrition Sales Growth Rate (2016-2021) Figure Global Blood-based Products Sales Growth Rate (2016-2021) Figure Global Others Sales Growth Rate (2016-2021) Figure Global Sterile Intravenous (IV) Solution Sales and Growth Rate (2021-2026) Figure Global Sterile Intravenous (IV) Solution Revenue and Growth Rate (2021-2026) Table Global Sterile Intravenous (IV) Solution Sales Forecast by Regions (2021-2026) Table Global Sterile Intravenous (IV) Solution Market Share Forecast by Regions (2021-2026) Figure North America Sales Sterile Intravenous (IV) Solution Market Forecast (2021-2026) Figure Europe Sales Sterile Intravenous (IV) Solution Market Forecast (2021-2026) Figure China Sales Sterile Intravenous (IV) Solution Market Forecast (2021-2026) Figure Japan Sales Sterile Intravenous (IV) Solution Market Forecast (2021-2026) Figure Southeast Asia Sales Sterile Intravenous (IV) Solution Market Forecast (2021-2026) Figure Other Regions Sales Sterile Intravenous (IV) Solution Market Forecast (2021-2026) Table Global Sterile Intravenous (IV) Solution Sales Forecast by Type (2021-2026) Table Global Sterile Intravenous (IV) Solution Market Share Forecast by Type (2021-2026) Table Global Sterile Intravenous (IV) Solution Sales Forecast by Application (2021-2026) Table Global Sterile Intravenous (IV) Solution Market Share Forecast by Application (2021-2026) Table Market Opportunities in Next Few Years Table Market Risks Analysis Table Market Drivers Figure Porter's Five Forces Analysis Table Macro Analysis of Upstream Markets Table Key Players in Upstream Markets Table Key Players of Upstream Markets Table Key Raw Materials Figure Price Trend of Key Raw Materials Table Key Suppliers of Raw Materials Figure Manufacturing Cost Structure of Sterile Intravenous (IV) Solution Table Macro Analysis of Down Markets Table Key Players in Down Markets Table Key Players of Downstream Markets Figure Sales Channel Figure North America Sterile Intravenous (IV) Solution Sales (K Units) Growth Rate Forecast (2020-2025) Figure North America Sterile Intravenous (IV) Solution Revenue (Million US$) Growth Rate Forecast (2020-2025) Figure Europe Sterile Intravenous (IV) Solution Sales (K Units) Growth Rate Forecast (2020-2025) Figure Europe Sterile Intravenous (IV) Solution Revenue (Million US$) Growth Rate Forecast (2020-2025) Figure Japan Sterile Intravenous (IV) Solution Production (K Units) Growth Rate Forecast (2020-2025) Figure Japan Sterile Intravenous (IV) Solution Revenue (Million US$) Growth Rate Forecast (2020-2025) Figure China Sterile Intravenous (IV) Solution Production (K Units) Growth Rate Forecast (2020-2025) Figure China Sterile Intravenous (IV) Solution Revenue (Million US$) Growth Rate Forecast (2020-2025) Figure Methodology/Research Approach Figure Market Size Estimation Figure Author List

B. Braun Medical Inc. Technoflex Baxter International ICU Medical, Inc Mckesson Amsino Wallcur Hebei Guangren Pharmaceutical Technology Jiangsu Hengfengqiang Biotechnology Hospira Jiangsu Hengfengqiang Biotechnology Hospira